Bifidobacteria possess inhibitory activity against dipeptidyl peptidase-IV. (Q40414082)

20 September 2017

title

Bifidobacteria possess inhibitory activity against dipeptidyl peptidase-IV. (English)

1 reference

20 September 2017

Z Zeng

1

1 reference

20 September 2017

J Y Luo

2

1 reference

20 September 2017

F L Zuo

3

1 reference

20 September 2017

R Yu

4

1 reference

20 September 2017

Y Zhang

5

1 reference

20 September 2017

H Q Ma

6

1 reference

20 September 2017

S W Chen

7

1 reference

20 September 2017

publication date

20 October 2015

1 reference

Letters in Applied Microbiology

20 September 2017

published in

1 reference

20 September 2017

volume

62

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

250-255

1 reference

Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase IV inhibitors

20 September 2017

cites work

1 reference

Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice.

21 January 2018

1 reference

Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review

21 January 2018

1 reference

Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?

21 January 2018

1 reference

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

Probiotic yogurt improves antioxidant status in type 2 diabetic patients.

21 January 2018

1 reference

Diabetes, obesity and gut microbiota

21 January 2018

1 reference

Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection.

21 January 2018

1 reference

Gut microbiota, probiotics and diabetes.

21 January 2018

1 reference

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 January 2018

1 reference

The anti-diabetic activity of Bifidobacterium lactis HY8101 in vitro and in vivo

21 January 2018

1 reference

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

Diabetes in Cushing syndrome: basic and clinical aspects

21 January 2018

1 reference

Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice

21 January 2018

1 reference

The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats

21 January 2018

1 reference

Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study

21 January 2018

1 reference

Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential

21 January 2018

1 reference

Factors influencing the composition of the intestinal microbiota in early infancy

21 January 2018

1 reference

Probiotics as beneficial agents in the management of diabetes mellitus: a systematic review

21 January 2018

1 reference

Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice

21 January 2018

1 reference

Metabolic activities and probiotic potential of bifidobacteria.

21 January 2018

1 reference

Probiotics: Considerations for Human Health

21 January 2018

1 reference

Dipeptidyl peptidase-IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in β-lactoglobulin

21 January 2018

1 reference

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

Isolation and Identification of Dipeptidyl Peptidase IV-Inhibitory Peptides from Trypsin/Chymotrypsin-Treated Goat Milk Casein Hydrolysates by 2D-TLC and LC-MS/MS.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LAM.12510

1 reference

20 September 2017

1 reference